德国ludwig-Maximilians大学神经免疫学研究博士后岗位
日期：2008-06-05
来源：丁香人才网
InstitutionLudwig-Maximilians University MunichPositionPost-Doc in NeuroimmunologyLocationMunich GermanyDate PostedJune 4th 2008Date ExpiresSeptember 3th 2008Tagspostdoc neuroimmunology neuroscience m ...
Institution
Ludwig-Maximilians University Munich
Position
Post-Doc in Neuroimmunology
Location
Munich, Germany
Date Posted
June 4th 2008
Date Expires
September 3th 2008
Tags
postdoc, neuroimmunology, neuroscience, munich, and germany
Description
Our Research Unit is supported by the Emmy-Noether Excellence Program ofthe German National Science Foundation and affiliated with the Instituteof Clinical Neuroimmunology of the Ludwig-Maximilians University Munichand the Dept. of Neuroimmunology of the Max-Planck-Institute of Neurobiology.
Our main focus is to develop new therapeutic strategies for multiplesclerosis a common neurological disease. In multiple sclerosis immunecells attack brain and spinal cord and damage nerve cells, theirconnections and the myelin sheets that isolate them. Our recent studiesindicate that a particular immune cell type, the macrophage, isprimarily responsible for tissue damage. However, while macrophagesmediate tissue damage in multiple sclerosis, they can in principle alsocontribute to CNS protection and repair (Kerschensteiner et al., 2003).This indicates that depending on the disease context macrophages can bepolarized towards distinct “destructive” or “protective” phenotypes. Theaim of this post-doctoral project is now to use a combination of in vivoimaging and ex vivo gene expression profiling to determine theregulatory factors that drive macrophages towards destruction or protection.
We are looking for hard-working, highly motivated applicants who arefluent in english and have a degree in a relevant field of study(biology, biochemistry, medicine). The start date for this position isnegotiable, but we aim for the fall of 2008. Funding for this project issecured through a grant by the German National Science Foundation.
Contact
If you would like to apply, please submit your letter of intent,curriculum vitae and names of two referees to:
Prof. Dr. Martin Kerschensteiner
Head of the Research Unit Therapy Development
Institute of Clinical Neuroimmunology, Ludwig-Maximilians-UniversityMunich, Marchioninistr. 17, 81377 Munich, Germany.
Email: Martin.Kerschensteiner@med.uni-muenchen.de
Selected recent publications of our group:munich
Misgeld, Kerschensteiner et al., Nature Methods, 4: 559-561 (2007)
Misgeld and Kerschensteiner, Nature Reviews Neuroscience 7:449-463 (2006)
Bareyre, Kerschensteiner et al., Nature Medicine 11:1355-1360 (2005)
Kerschensteiner et al., Nature Medicine 11:572-577 (2005)
Bareyre, Kerschensteiner et al., Nature Neuroscience 7: 269-277 (2004)
Kerschensteiner et al., Journal of Experimental Medicine 200: 158-170 (2004)
Kerschensteiner et al., Annals of Neurology 53:292-304 (2003)
Ludwig-Maximilians University Munich
Position
Post-Doc in Neuroimmunology
Location
Munich, Germany
Date Posted
June 4th 2008
Date Expires
September 3th 2008
Tags
postdoc, neuroimmunology, neuroscience, munich, and germany
Description
Our Research Unit is supported by the Emmy-Noether Excellence Program ofthe German National Science Foundation and affiliated with the Instituteof Clinical Neuroimmunology of the Ludwig-Maximilians University Munichand the Dept. of Neuroimmunology of the Max-Planck-Institute of Neurobiology.
Our main focus is to develop new therapeutic strategies for multiplesclerosis a common neurological disease. In multiple sclerosis immunecells attack brain and spinal cord and damage nerve cells, theirconnections and the myelin sheets that isolate them. Our recent studiesindicate that a particular immune cell type, the macrophage, isprimarily responsible for tissue damage. However, while macrophagesmediate tissue damage in multiple sclerosis, they can in principle alsocontribute to CNS protection and repair (Kerschensteiner et al., 2003).This indicates that depending on the disease context macrophages can bepolarized towards distinct “destructive” or “protective” phenotypes. Theaim of this post-doctoral project is now to use a combination of in vivoimaging and ex vivo gene expression profiling to determine theregulatory factors that drive macrophages towards destruction or protection.
We are looking for hard-working, highly motivated applicants who arefluent in english and have a degree in a relevant field of study(biology, biochemistry, medicine). The start date for this position isnegotiable, but we aim for the fall of 2008. Funding for this project issecured through a grant by the German National Science Foundation.
Contact
If you would like to apply, please submit your letter of intent,curriculum vitae and names of two referees to:
Prof. Dr. Martin Kerschensteiner
Head of the Research Unit Therapy Development
Institute of Clinical Neuroimmunology, Ludwig-Maximilians-UniversityMunich, Marchioninistr. 17, 81377 Munich, Germany.
Email: Martin.Kerschensteiner@med.uni-muenchen.de
Selected recent publications of our group:munich
Misgeld, Kerschensteiner et al., Nature Methods, 4: 559-561 (2007)
Misgeld and Kerschensteiner, Nature Reviews Neuroscience 7:449-463 (2006)
Bareyre, Kerschensteiner et al., Nature Medicine 11:1355-1360 (2005)
Kerschensteiner et al., Nature Medicine 11:572-577 (2005)
Bareyre, Kerschensteiner et al., Nature Neuroscience 7: 269-277 (2004)
Kerschensteiner et al., Journal of Experimental Medicine 200: 158-170 (2004)
Kerschensteiner et al., Annals of Neurology 53:292-304 (2003)
微信扫一扫分享资讯
- 相关阅读
本科起 1.5 万一次性补贴 | 深圳就业福利、医院实力综述
深圳，向往的地方！
合肥市口腔医院急聘口腔专业博士、硕士
安徽省内唯一一家三级口腔专科医院，创建于1956年，历经六十年的风雨兼程，已发展成为集医、教、研、防为一体的现代化口腔专科医院，并形成了“一院、两区、三部”的格局，现在面向全国急招口腔方面专业人才，欢迎您的投递！
